The prognostic outcomes for each subtype exhibit substantial variability [36], making it imperative to establish differentiated follow-up monitoring strategies on the basis of molecular typing, particularly for HER2-positive and triple-negative subtypes, which require enhanced posttreatment imaging surveillance and circulating tumour DNA detection
Synovial sarcoma, arising as it does in an undifferentiated mesenchymal precursor, can rarely present as a primary skin neoplasm
Immunohistochemistry Analysis The sections were incubated with citrate antigen retrieval solution for 20 min at 95C
*Correspondence: Hongjun Li, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
It also provides comparison periods to evaluate whether the peptide is actually contributing to your results